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Abstract 
Background: The association of longitudinal trajectories of cardiovascular risk factors with cardiovascular magnetic 
resonance (CMR)-measures of cardiac structure and function in the community is not well known. Therefore we 
aimed to relate risk factor levels from different examination cycles to CMR-measures of the left ventricle (LV) and right 
ventricle in a population-based cohort.
Methods: We assessed conventional cardiovascular disease risk factors in 349 participants (143 women; aged 
25–59 years) at three examination cycles (Exam 1 [baseline], at Exam 2 [7-years follow-up] and at Exam 3 [14-years 
follow-up]) of the KORA S4 cohort and related single-point measurements of individual risk factors and longitudinal 
trajectories of these risk factors to various CMR-measures obtained at Exam 3.
Results: High levels of diastolic blood pressure, waist circumference, and LDL-cholesterol at the individual exams 
were associated with worse cardiac function and structure. Trajectory clusters representing higher levels of the indi-
vidual risk factors were associated with worse cardiac function and structure compared to low risk trajectory clusters 
of individual risk factors. Multivariable (combining different risk factors) trajectory clusters were associated with differ-
ent cardiac parameters in a graded fashion (e.g. decrease of LV stroke volume for middle risk cluster β = − 4.91 ml/m2, 
95% CI − 7.89; − 1.94, p < 0.01 and high risk cluster β = − 7.00 ml/m2, 95% CI − 10.73; − 3.28, p < 0.001 compared to 
the low risk cluster). The multivariable longitudinal trajectory clusters added significantly to explain variation in CMR 
traits beyond the multivariable risk profile obtained at Exam 3.
Conclusions: Cardiovascular disease risk factor levels, measured over a time period of 14 years, were associated with 
CMR-derived measures of cardiac structure and function. Longitudinal multivariable trajectory clusters explained a 
greater proportion of the inter-individual variation in cardiac traits than multiple risk factor assessed contemporane-
ous with the CMR exam.
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Introduction
The association of standard cardiovascular disease 
(CVD)  risk factors with prevalent and incident CVD 
events [1–3] and with subclinical CVD traits, including 
parameters of left ventricular (LV) remodeling, is well 
established [4, 5]. In most studies, however, these risk 
factors were obtained only at one point in time. Data 
on longitudinal trajectories of risk factors and on the 
associations of these trajectories with subclinical and 
clinical CVD are limited [6]. In this context, it is not 
well known, whether information about cumulative risk 
factor burden over an extended period of time is more 
strongly related to clinical and subclinical CVD traits 
than measurements of CVD risk factors at one point in 
time (e. g. contemporaneous with the measurement of 
the CVD endpoint or trait) [7].
Cardiovascular magnetic resonance (CMR) is 
increasingly being used in population-based cohorts to 
measure in a more sensitive and specific way subclini-
cal alterations of the cardiovascular system [8]. Few 
prior studies have related cardiac CMR-derived meas-
ures to established CVD risk factors, including systolic 
blood pressure (BP), body mass index (BMI) and total 
cholesterol, obtained at one point in time [9, 10]. These 
studies reported statistically significant associations, 
e. g. with LV end-diastolic volume, myocardial mass 
and ejection fraction [9, 10]. However, measurements 
of risk factors at one point in time do not adequately 
reflect long term exposure to risk factors and it is con-
ceivable that cumulative exposure measures reflect 
cardiovascular risk better than single occasion meas-
urements of one or multiple risk factors.
It is, therefore, of interest to evaluate the associa-
tions of CVD factors, measured repeatedly at different 
examination cycles, with CMR-parameters. In addition 
to the already established CMR markers mentioned 
above (e. g., myocardial mass), CMR provides a wide 
range of emerging measurements of cardiac structure 
and function including right ventricle (RV) function 
and epi- and pericardial fat that are available for further 
investigations [11, 12].
The secondary aims of the present study were to 
relate (i) 5 specific risk factor levels (systolic BP, 
diastolic BP, waist circumference, hemoglobin A1c 
(HbA1c), low density lipoprotein (LDL-C) from three 
individual exams (each about 7  years apart) as well as 
(ii) longitudinal trajectories of these individual CVD 
risk factors over 14  years to subclinical CMR-meas-
ures of LV volumes and mass, RV volumes and mass, 
and cardiac fat in a general population cohort (KORA 
project, conducted in southern Germany). The primary 
aim was to relate longitudinal clusters (over 14 year of 
follow-up) of multiple CVD risk factors to CMR traits 
independently of cross-sectional multiple risk factor 
clusters.
We hypothesized that (i) CVD risk factors levels meas-
ured contemporaneous with the CMR examination 
(Exam 3) are more strongly related to CMR traits than 
risk factor levels from more remote exams, and (ii) that 
trajectory clusters, which include information on the 
long-term trajectory of individual CVD  risk factors are 
strongly related to CMR traits. Third, we hypothesized 
that trajectory clusters including multiple CVD risk fac-
tors and their change over time add more explanation to 
the inter-individual variation in CMR traits than multiple 




The KORA S4 study (“Cooperative Health Research in 
the Region of Augsburg”) is a population-based cohort 
conducted in the city of Augsburg (Southern Germany) 
and two surrounding counties between 1999 and 2001 
(baseline examination). Of all 4261 participants of the 
baseline examination cycle (Exam 1), 3080 individuals 
also participated in the 7-year follow-up examination 
(2006–2008; Exam 2) and 2279 subjects also participated 
in the 14-year follow-up examination (2013–2014; Exam 
3) [13]. At Exam 3, a total of 400 participants without a 
history of stroke, myocardial infarction, and arterial ves-
sel occlusion were examined by 3 T CMR in the KORA 
CMR sub-study that was planned with sufficient power 
for several analyses of subclinical cardiovascular disease 
differences in different risk groups [14]. Participants with 
missing data for cardiac imaging (n = 20), non-partici-
pation in Exam 2 (n = 18) and with missing data on risk 
factors and potential confounders at any of the Exams 
(n = 13) were excluded from the present analysis, yield-
ing an analytical sample of 349 participants (143 women; 
aged 39 to 73 years) (Fig. 1).
CMR examination and CMR‑derived cardiac measurements
CMR examinations were performed on a 3  T system 
(Magnetom Skyra, Siemens Healthineers, Erlangen, Ger-
many) using an 18 channel body array coil in combination 
Keywords: Cardiac MRI, Cardiac function and structure, Risk factors, Cohort study
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with the table-mounted spine matrix coil [14]. Individu-
als were scanned in a supine position.
Left ventricle (LV)
Cine-balanced steady state free precession (bSSFP) 
sequences were evaluated semi-automatically using com-
mercially available software (CVi42, Circle Cardiovascu-
lar Imaging, Calgary, Canada) by two alternative readers. 
Following automatic contour detection of the LV endo-
cardium, all borders were corrected manually if neces-
sary and according to current guidelines in order to avoid 
erroneous tracing of the myocardial border. Certification 
measurements prior to the analyses proved good repro-
ducibility of the two readers with relative differences of 
less than 5% for LV volumes and ejection fraction [15]. 
For determination of filling and ejection rates, the time 
course of LV volume changes was quantified using asso-
ciated gradients and time lags by using the dedicated 
in-house software. This software displays the LV volume 
versus time curve along with its derivative and estimates 
peak gradients during early, passive LV filling and late LV 
filling due to atrial contraction.
Right ventricle (RV)
Evaluation of RV parameters was performed using dedi-
cated software (CVi42, Circle Cardiovascular Imaging 
Inc.) by one blinded, well-trained reader. Inter-reader 
(with other expert in cardiac imaging) and intra-reader-
comparisons on 38 (9.5%) and 33 (8.3%) participants, 
respectively, were performed as part of the KORA qual-
ity control procedures. Deviations relative differences 
were < 5% for all parameters. End-diastole was defined as 
the phase with the biggest RV  volume. End-systole was 
defined as the phase with the smallest RV volume. In 
the end-diastolic and end-systolic phase the contours of 
the RV lumen were manually delineated. The papillary 
muscles were included in the RV lumen. Slices from the 
apex up to the pulmonary valve were included in RV vol-
ume. The RV outflow tract was attributed to the RV [16]. 
For analysis, LV and RV volumes, as well as LV diastolic 
mass, were indexed to body surface area.
Cardiac fat
Analyses of the local fat compartments were conducted 
with a dedicated segmentation software (OsiriX Lite; 
Pixmeo SARL, Bernex, Switzerland). Epicardial fat was 
defined as the fat located inside the visceral layer of the 
pericardial sac in close proximity to the myocardium. 
Paracardial fat was defined as the fat compartment 
located outside of the pericardial sac. Together, these two 
fat compartments are summarized as pericardial fat. Epi-
cardial and pericardial fat were assessed in Cine-bSSFP 
Fig. 1 Flow chart of the KORA study sample (N = 349) and the cohort study design. (*N = 118 participants skipped Exam 2, but attended Exam 3)
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sequences (four chamber view) using only the diastolic 
phase and were segmented manually. Small non-fatty 
structures (e.g. coronary arteries) in the fat compart-
ments were not segmented individually [17]. Data are 
given as an area in  cm2.
For the main analyses, we investigated CMR param-
eters that were most strongly correlated with CVD risk 
factors in previous studies of this sample (LV: end-dias-
tolic volume, stroke volume, diastolic myocardial mass, 
early diastolic filling rate; RV: end-diastolic volume, 
stroke volume; fat: epicardial, diastolic) [14, 16–18].
Risk factor measurements
The aim of the study was to focus on 5 selected main 
cardiovascular risk factors (systolic BP, diastolic BP, 
waist circumference, HbA1c, LDL-C) that were modifi-
able, clinically measureable, lowly inter-correlated, and 
of a continuous measurement character. At each exami-
nation cycle, systolic and diastolic BP were measured 
three times at the right arm of seated participants after 
a minimum resting period of 5  min and a time interval 
of 3 min between measurements. An oscillometric digital 
BP monitor (HEM-705CP, Omron Corporation, Tokyo, 
Japan) and a cuff of appropriate size were used. The mean 
of the second and third BP measurements was used for 
the present analyses [19].
Waist circumference was measured with an inelastic 
multi-colored measuring tape (Fa Hoechstmass) in cm to 
the closest 0.1 cm. Waist circumference was measured at 
the level midway between the lower rib margin and the 
iliac crest while the participants breathed out gently.
Laboratory measurements including HbA1c, total cho-
lesterol, high- and low-density lipoprotein cholesterol 
(HDL-C, LDL-C) were performed as described else-
where [13]. Briefly, for the assessment of total choles-
terol, LDL-C and HDL-C, enzymatic, photometric assays 
were used at the baseline examination and enzymatic, 
colorimetric Flex assays were used at Exam 2 and Exam 
3. HbA1c was measured by a turbidimetric inhibition 
immunoassay at baseline (S4) and by cation-exchange 
high performance liquid chromatographic, photometric 
assays at Exam 2 and 3.
Covariates
Further health-related variables were measured in a com-
parable fashion in all three KORA examination cycles by 
standardized interview and in a comprehensive physi-
cal examination. Participants were classified as never-
smoker, ex-smoker or current smoker. Pack-years were 
calculated by multiplying the number of packs of ciga-
rettes smoked per day by the number of years the par-
ticipant has smoked. Participants were classified as being 
physically active if they did regular sports in summer 
and winter and were active for ≥ 1 h per week in at least 
one season or as physically inactive if they did less sports 
[20]. Alcohol intake was assessed using a validated recall 
method, calculating alcohol intake in grams per day from 
participants’ self-reported intake of beer, wine, sparkling 
wine or distilled spirits over the previous weekend and 
workday [21].
Diabetes was self-reported or defined by the use of 
glucose-lowering medication. Hypertension was defined 
as systolic BP ≥ 140  mmHg or diastolic BP ≥ 90  mmHg 
[22] or the use of antihypertensive medication under the 
awareness of having hypertension. Medication intake 
within the last seven days was recorded during a medical 
interview by computer-based software, and participants 
were also asked to bring their medication packages with 
them.
Weight and height were determined by Seca’s measur-
ing systems (Seca GmbH & Co, KG, Hamburg, Germany; 
[weight: Exam 1: SECA 709, Exam 2: SECA 709, Exam 3: 
SECA 635 or SECA 877 or SECA measuring station 285; 
height: Exam 1: SECA 221, Exam 2: SECA 242, Exam 
3: SECA 242]) with either calibrated steelyards or digi-
tal scales allowing accurate measurements up to 0.1  kg 
and 0.1  cm, respectively. BMI was calculated as weight 
divided by squared height (kg/m2).
waist circumference was divided by hip circumference 
to get waist-hip-ratio (WHR) and by height to get waist-
height-ratio (WHtR). Hip circumference was measured 
at the widest protrusion of the gluteal region between the 
superior border of the iliac crest and crotch. Body surface 
area (BSA) was calculated according to the Du Bois for-
mula (BSA = 0.007184 × (height in cm)0.725 × (weight in 
kg)0.425) [23].
Statistical analyses
For each KORA examination cycle, descriptive character-
istics of participants are provided as means with standard 
deviations for continuous measurements and as absolute 
numbers and proportions for categorical measurements. 
Differences in participant characteristics between differ-
ent KORA examination cycles were evaluated by one-
way repeated measures ANOVA (continuous data) or 
Cochran’s Q test (categorical data) [24]. MRI parameters 
from Exam 3 were also summarized as means with stand-
ard deviations.
Association of risk factor levels from individual exams 
with CMR traits
Associations of five risk factors from three individual 
exams (each risk factor at each exam considered sepa-
rately as independent variables) with different CMR-
derived parameters of cardiac function and structure 
(dependent variables) were assessed by multivariable 
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linear regression models (providing β-coefficients with 
95% confidence intervals). The following risk factors 
were used as exposure variables: systolic BP, dias-
tolic BP, waist circumference, HbA1c and LDL-C. The 
models included the following potential confounders 
(obtained at each exam): age, sex, smoking status, alco-
hol consumption, physical activity, antihypertensive 
medication, lipid-lowering medication, and glucose-
lowering medication. The explained outcome variance 
for each model was measured by the Goodness-Of-Fit 
statistic  R2.
Derivation of risk factor trajectory clusters
Longitudinal risk factor trajectory clusters were derived 
by non-parametric k-means clustering [25, 26]. Measure-
ments of 5 risk factors (systolic and diastolic BP, waist cir-
cumference, HbA1c and LDL-cholesterol), each obtained 
at the three examination cycles (Exams 1–3) were used 
as input values. Individuals with a high similarity regard-
ing mean values at Exam 1–3 and regarding change in 
risk factor levels between exams were clustered together, 
whereas participants with lower similarity in risk factor 
levels and trajectories were assigned to different clusters 
[27]. Similarity was determined by the Euclidean dis-
tance—the shorter the Euclidean distance between two 
subjects, the more similar the subjects are.
For individual risk factor trajectories, only the values 
of a single risk factor at Exams 1–3 were considered. 
For multivariable risk factor trajectories, the values of 
all five risk factors were considered conjointly: In the 
multivariate k-means algorithm each subject is repre-
sented as a data matrix with columns denoting the time 
points of measurements and rows denoting the differ-
ent risk factors. Values are then subsumed by calculating 
the distance between the column vectors and applying a 
mathematical norm function on the resulting vector of 
distances [25, 26].
As there is no established criterion to determine the 
“correct” number k of clusters for a k-means algorithm, 
a combination of domain knowledge and heuristic crite-
ria was used. To obtain informative clusters, the possible 
number of clusters was pre-set to be > 2 but < 8. Of the 
resulting set of possible number of clusters, all numbers 
were tested on the multivariable risk factor trajectories. 
The final number was determined by maximizing the 
Calinski-Harabasz Index [28], which is essentially given 
by the ratio of the variance between clusters to the vari-
ance within clusters. The index is, therefore, maximized 
for clusters which are compact and well separated from 
each other. Based on this criterion, the optimal number 
of clusters was three, representing low, middle and high 
cumulative exposure to the respective risk factors over 
14 years. Consequently, k = 3 was also used for the indi-
vidual risk factor trajectories.
Association of individual risk factor trajectories with CMR 
traits
CVD risk factor trajectories for individual risk factors 
were displayed graphically by plotting the mean risk fac-
tor level in each of the three clusters (low, middle and 
high exposure) at each of the Exams. The associations of 
the trajectory clusters with the different CMR outcomes 
were analyzed by multiple linear regression, adjusted 
for the potential confounders as detailed above. Mod-
els including trajectory clusters of individual risk fac-
tors were additionally adjusted for the other remaining 4 
CVD risk factors. Thus, the trajectory cluster for systolic 
BP was adjusted for the confounders listed above and in 
addition for diastolic BP, HbA1c, waist circumference 
and LDL-C (all measured at Exam 3, contemporaneous 
with the CMR).
Association of multiple risk factor trajectories with CMR traits
To quantify the associations of the multivariable risk 
clusters with different CMR outcomes, adjusted pre-
dicted means of the different CMR traits were stratified 
by clusters (reflecting low, moderate and high cumulative 
exposure to multiple CVD risk factors over 14 years) and 
were displayed graphically using the estimates of multi-
variable linear regression models. Also these analyses 
were adjusted for the potential confounders as detailed 
above.
To investigate the incremental value of longitudinal 
information from multiple risk factor beyond multiple 
risk factor information from Exam 3 (contemporaneous 
with the CMR; cross-sectional) for the explanation of 
CMR outcomes, a likelihood ratio (LR) test was applied, 
comparing a model with multivariable risk factors clus-
ters from Exam 3 only (cross-sectional) to a model which 
includes longitudinal multivariable risk factor trajectory 
cluster (over 14 years) and the cross-sectional multivari-
able risk factor cluster from Exam 3.
A two-sided p-value of < 0.05 was considered statisti-
cally significant. For the final main analyses including 
eight LR-tests we adjusted the level of significance by 
p < 0.05/8 (= 0.0063). Statistical analyses were performed 
using Stata 16.1 (Stata Corporation, College Station, 
Texas, USA) and R 3.4.1 (R Core Team, Vienna, Austria).
Results
Over the 14-year period from Exam 1 to Exam 3, we 
observed an increase in hypertension prevalence (29–
33%), and in mean levels of HbA1c (5.48–5.56%), waist 
circumference (90.6–98.4  cm) and LDL-cholesterol 
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(133.0–138.9  mg/dl; Table  1). Furthermore, mean sys-
tolic and diastolic BP decreased slightly from Exam 1 to 
Exam 3, whereas the intake of antihypertensive medi-
cation increased substantially from 7.7 to 24.9%, which 
might contribute to the decrease in mean systolic 
BP over time, since it is well established that systolic 
BP usually increases with age [29]. The prevalence of 
smokers dropped from 27% (Exam 1) to 20% (Exam 3), 
whereas the proportion of physically active participants 
increased from 51% (Exam 1) to 61% (Exam 3; Table 1).
Characteristics of CMR-derived parameters of car-
diac function and structure, measured at Exam 3 are 
summarized in Table 2.
Individual cardiovascular disease risk factors from Exam 
1–3 and cardiac remodeling traits and fat
The associations of 5 main CVD risk factors (systolic 
and diastolic BP, waist circumference, HbA1c and 
LDL-C) from three examination cycles with various 
CMR outcome variables are displayed in Additional 
file 1: Table S1. In essence, diastolic BP, waist circum-
ference and LDL-C displayed consistent inverse associ-
ations with end-diastolic volumes and stroke volumes 
of the LV and the RV, respectively, across the three 
examination cycles. The strength of association was 
slightly stronger for BP traits and waist circumference 
from Exam 2 and 3 (contemporaneous with the CMR) 
Table 1 Cardiovascular disease risk factors at Exam 1, Exam 2 and Exam 3 (N = 349)
Data are given as number (percentage) or mean (± standard deviation)
BP blood pressure, HbA1c hemoglobin A1c, HDL-C high-density-lipoprotein cholesterol, LDL-C low-density-lipoprotein cholesterol
* One-way repeated measures ANOVA (continuous data) or Cochran’s Q test (categorical data)
Exam 1 (1999–2001) Exam 2 (2006–2008) Exam 3 (2013–2014) p value*
Age (years) 42.5 (± 9.2) 49.5 (± 9.2) 56.5 (± 9.2) –
Males 206 (59.0%) 206 (59.0%) 206 (59.0%) –
Systolic BP (mmHg) 126.2 (± 16.1) 121.1 (± 16.2) 120.2 (± 16.1)  < 0.001
Diastolic BP (mmHg) 81.6 (± 10.3) 76.6 (± 9.4) 75.2 (± 9.8)  < 0.001
Hypertension 101 (28.9%) 91 (26.1%) 115 (33.0%) 0.009
Weight (kg) 78.8 (± 13.6) 81.4 (± 15.2) 82.8 (± 16.2)  < 0.001
Height (cm) 171.9 (± 9.6) 172.5 (± 9.8) 171.9 (± 9.9)  < 0.001
Body mass index (kg/m2) 26.6 (± 3.8) 27.3 (± 4.2) 28.0 (± 4.7)  < 0.001
Waist circumference (cm) 90.6 (± 11.6) 93.8 (± 12.9) 98.4 (± 13.8)  < 0.001
Hip circumference (cm) 104.4 (± 7.1) 106.0 (± 7.9) 106.7 (± 8.8)  < 0.001
Waist-hip-ratio 0.87 (± 0.08) 0.88 (± 0.08) 0.92 (± 0.09)  < 0.001
Waist-height-ratio 0.53 (± 0.06) 0.54 (± 0.07) 0.57 (± 0.08)  < 0.001
Body surface area  (m2) 1.91 (± 0.2) 1.95 (± 0.21) 1.95 (± 0.22)  < 0.001
Smoking status
 Never-smoker 131 (37.5%) 131 (37.5%) 131 (37.5%) –
 Ex-smoker 124 (35.5%) 140 (40.1%) 148 (42.4%) 0.001
 Current smoker 94 (26.9%) 78 (22.4%) 70 (20.1%) 0.001
Pack-years 10.8 (± 16.6) 12.3 (± 18.4) 13.1 (± 19.3)  < 0.001
Alcohol consumption (g/day) 19.2 (± 25.9) 18.8 (± 24.4) 19.1 (± 24.4) 0.734
Physically active 178 (51%) 205 (58.7%) 212 (60.7%) 0.002
Diabetes mellitus 4 (1.2%) 13 (3.7%) 28 (8.0%) 0.003
HbA1c (%) 5.48 (± 0.47) 5.48 (± 0.53) 5.56 (± 0.71)  < 0.001
Total cholesterol (mg/dl) 223.0 (± 40.6) 215.5 (± 37.4) 217.3 (± 36.4)  < 0.001
HDL-C (mg/dl) 56.2 (± 16.6) 54.1 (± 13.7) 62.5 (± 17.4)  < 0.001
LDL-C (mg/dl) 133.4 (± 39.1) 137.7 (± 33.7) 138.9 (± 32.9) 0.011
Antihypertensive medication 27 (7.7%) 53 (15.2%) 87 (24.9%) 0.034
Lipid-lowering medication 7 (2%) 23 (6.6%) 36 (10.3%) 0.003
Glucose-lowering medication 4 (1.2%) 9 (2.6%) 26 (7.5%) 0.003
Statin medication 7 (2%) 20 (5.7%) 36 (10.3%) 0.003
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than with the risk factors from Exam 1. WC and, to a 
certain extent also diastolic BP, were positively associ-
ated with epicardial and/or pericardial fat (Additional 
file 1: Table S1).
Systolic BP was most consistently associated with 
LV stroke volume and myocardial mass. These asso-
ciations were slightly stronger for systolic BP meas-
urements obtained at Exam 2 and 3, as compared to 
systolic BP obtained at Exam 1 (Additional file  1: 
Table S1).
By contrast, HbA1c did not provide evidence for 
a consistent association with CMR traits of cardiac 
structure and function or with cardial fat, even though 
we observed a statistically significant association of 
HbA1c from the Exam 3 with stroke volume and myo-
cardial mass. However, these associations could not be 
confirmed with HbA1c levels assessed at the Exam 1 
and 2 (Additional file 1: Table S1).
In aggregate, the risk factor profiles from the Exam 
3 (contemporaneous with the CMR measurements) 
explained slightly more variation in the different CMR 
outcomes than the risk factor levels obtained at base-
line or at Exam 2:  R2-values for the regression models 
increased slightly but consistently for all cardiac func-
tion and structure parameters from the first to the 
third examination cycle (Additional file 1: Table S1).
Individual Risk factor trajectory clusters and cardiac 
remodeling
For each risk factor, we defined three trajectory clusters 
based on mean risk factor levels and the change of the 
risk factors over time (Fig.  2). Individuals with similar 
mean values and comparable longitudinal trajectories 
were grouped together, as detailed in the methods sec-
tion. In the high and low-level clusters, mean values for 
systolic and diastolic BP decreased whereas mean val-
ues for waist circumference increased over the 14  year 
follow-up period (Fig. 2). Mean HbA1c values increased 
substantially in the high level cluster (reflecting a higher 
proportion of incident diabetes cases; n = 15), but 
remained essentially unchanged in the middle (incident 
diabetes cases n = 9) and low-level cluster (n = 0). Mean 
LDL-C levels slightly decreased in the high-level cluster, 
whereas LDL-C levels in the middle and low-level cluster 
slightly increased.
The association of the different individual CVD risk 
factor trajectory clusters with CMR measures is displayed 
in Table 3. Consistent with the associations of individual 
risk factors measurements (Additional file  1: Table  S1), 
the clusters representing high cumulative exposure 
(high mean levels) of waist circumference, diastolic BP 
and LDL-C displayed the most consistent evidence for 
association with end-diastolic diameters and stroke vol-
umes of the LV and the RV (inverse associations) as well 
as with epi- and pericardial fat (positive associations for 
waist circumference and diastolic BP) (Table 3). For waist 
circumference, the mid-level trajectory cluster displayed 
a comparable pattern of association (same directionality, 
lower strength of association) as the high level trajectory 
(Table 3).
Multivariable CVD risk factor trajectory clusters 
and cardiac remodeling
We also estimated multivariable trajectory clusters, 
taking into account longitudinal information from all 
five CVD risk factors (systolic and diastolic BP, waist 
circumference, HbA1c, LDL-C). These multivariable 
risk factor trajectories were clearly and consistently 
associated with nearly all CMR traits, except for LV 
mass (which was specifically related to high systolic 
BP), and with epicardial and pericardial fat. Figure  3 
displays the adjusted means of all CMR traits according 
to the three multivariable risk factor trajectory clusters. 
In essence, we observed a graded relation between the 
multivariable trajectory clusters and most CMR traits 
in the sense that higher exposure to multiple risk fac-
tors over time (the middle risk and the high risk trajec-
tories) was associated with lower end-diastolic volumes 
of the LV and RV, lower stroke volumes of the LV and 
Table 2 Cardiovascular magnetic resonance (CMR) traits 
of  cardiac function and  structure, obtained at  Exam 3, 
stratified by sex (N = 349)
Data are given as mean (± standard deviation)
MRI traits Exam 3 (2013–2014)
Women (n = 143) Men (n = 206)
Left ventricle
 End-diastolic volume (ml) 116.1 (± 26.7) 139.0 (± 34.2)
 End-systolic volume (ml) 34.1 (± 15.0) 45.6 (± 19.0)
 Stroke volume (ml) 82.1 (± 17.4) 93.4 (± 21.6)
 Ejection fraction (%) 71.3 (± 7.0) 67.9 (± 8.1)
 Myocardial mass, diastolic (g) 114.6 (± 25.9) 159.3 (± 27.7)
 Myocardial mass, systolic (g) 113.7 (± 26.7) 164.5 (± 30.8)
 Early diastolic filling rate (ml/s) 224.4 (± 105.8) 227.2 (± 120.9)
 Peak ejection rate (ml/s) 328.7 (± 106.4) 373 (± 146.8)
Right ventricle
 End-diastolic volume (ml) 143.1 (± 30) 181.7 (± 38.5)
 End-systolic volume (ml) 63.6 (± 18.4) 90.7 (± 24.4)
 Stroke volume (ml) 79.5 (± 16.9) 91.1 (± 20.2)
 Ejection fraction (%) 55.8 (± 6.4) 50.4 (± 6.6)
Cardiac fat
 Epicardial fat, diastolic  (cm2) 6.6 (± 3.5) 9.2 (± 4.3)
 Pericardial fat, diastolic  (cm2) 18.6 (± 9.8) 33.0 (± 16)
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RV, lower LV diastolic filling rate, as well as with higher 
levels of epicardial and pericardial fat.
Model A in Table 4 denotes the cross-sectional asso-
ciation of multivariable risk factor clusters from Exam 
3 with CMR traits. Once longitudinal information from 
the multivariable risk factor trajectory clusters is added 
to the cross-sectional multivariable risk clusters from 
Exam 3 (Table 4; Model B), the model fit improved [LR 
tests were statistically significant (Table  4)], and the 
risk factor clusters from Exam 3 only were no longer 
statistically significant whereas the longitudinal mul-
tivariable risk factor trajectory clusters were statisti-
cally significantly associated with various CMR traits 
(Table 4; Model B).
Thus, the (longitudinal) multivariable trajectory clus-
ters added significant information in explaining variation 
of the various CMR traits beyond the multivariable risk 
profile obtained at Exam 3 (contemporaneous with the 
CMR exam, Table 4, all p values ≤ 0.011, except for myo-
cardial mass). Results of further risk factor clusters and 
CMR parameters are available in Additional file 1: Tables 
S2, S3 and S4, respectively. Sensitivity analyses with 
adjustment for covariates from Exam 1 (Additional file 1: 
Table S5) did not reveal substantially different results.
Discussion
In a general population cohort, we investigated the asso-
ciations of individual CVD risk factors from three exami-
nation cycles (covering a period of 14  years from Exam 
1 to Exam 3) with CMR measures obtained at Exam 3. 
We also assessed how strong longitudinal trajectory clus-
ters of individuals risk factors were associated with CMR 
measures and whether longitudinal trajectory clusters of 
multiple CVD risk factors add information to risk fac-
tor measurements obtained concurrent to the CMR with 
respect to explaining variation in CMR measures.
Principal observations
The results can be summarized as follows: First, indi-
vidual measurements of diastolic BP, waist circumfer-
ence and LDL-C were consistently, inversely associated 
with LV and RV stroke volumes and end-diastolic vol-
umes. The association of these risk factors with CMR 
traits was slightly stronger for risk factors from Exam 2 
Fig. 2 Change in mean levels for cardiovascular disease (CVD) risk factors from Exam 1 (baseline) to Exam 2 (7-year follow-up) and Exam 3 (14-year 
follow-up) for the three clusters derived from each individual CVD risk factor, respectively (grouping individuals with similar mean levels and 
trajectories (solid line = low level cluster, long dashed line = middle level cluster and short dashed line = high level cluster) (N = 349)
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and 3 (closer to the CMR exam conducted at Exam 3), 
compared to Exam 1. Second, mainly waist circumfer-
ence, but also diastolic BP were associated with cardiac 
fat depots. Third, systolic BP was most significantly 
associated with myocardial mass, and—to some extent—
with LV stroke volume. Fourth, HbA1c did not display 
a consistent pattern of association with CMR traits or 
epi- and pericardial fat. Fifth, long-term exposure to high 
Table 3 Associations of  trajectory clusters for  individual CVD risk factors (representing low, medium and  high 
cumulative exposure to this risk factor over 14 years) with CMR derived measures of cardiac structure and function
Data are β coefficients (with 95% confidence interval; indicating change in outcome variable between reference cluster and risk factor cluster) from multivariable 
linear regression models adjusted for the other risk factors respectively and for age, sex, smoking status, alcohol consumption, physical activity, antihypertensive 
medication, lipid-lowering medication, glucose-lowering medication measured in Exam 3
Ref. reference cluster
***p < 0.001; **p < 0.01; *p < 0.05
a Clusters were calculated by k-means clustering
b Indexed to body surface area
CV risk factor 
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levels of diastolic BP, waist circumference and LDL-C 
(high risk factor levels trajectories) displayed statistically 
significant associations with end-diastolic volumes and 
stroke volumes of both ventricles. Sixth, long-term expo-
sure to high and medium levels of several risk factors 
(multivariable trajectory clusters) displayed strong and 
consistent associations with multiple CMR traits and fat 
depots and added additional information for the explana-
tion of CMR outcomes beyond multivariable risk meas-
urement from Exam 3 (concurrent to the CMR exam).
Association of individual risk factor measurements 
with cardiac remodeling
We observed consistent associations of diastolic BP, waist 
circumference and LDL-C with LV and RV end-diastolic 
and stroke volume. While the associations of these CVD 
risk factors from Exam 2 and 3 were slightly stronger 
than with risk factors measured at Exam 1, defined risk 
factors from Exam 1 also displayed significant associa-
tions with CMR traits obtained 14 years later at Exam 3. 
In essence, Exam 1 BP traits and LDL-C were associated 
with LV mass and stroke volume and Exam 1 waist cir-
cumference was related to RV parameters and to cardiac 
fat depots.
The inverse association of diastolic BP, waist circumfer-
ence and LDL-C with filling rates, end-diastolic volume 
and stroke volume could be consistent with these risk 
factors contributing to smaller stiffer ventricles which are 
potential precursors of heart failure with preserved ejec-
tion fraction later in life [30].
Prior studies provided cross-sectional evidence for 
associations of standard cardiovascular risk factors with 
subclinical cardiac remodeling [9–11, 31]. In a sample 
of the UK Biobank, the impact of several modifiable risk 
factors on CMR-measured subclinical alterations of all 
four cardiac chambers was analyzed [10]. Similarly to our 
study, higher systolic BP was related to higher LV mass 
and volumes while higher diastolic BP and higher choles-
terol levels were related to lower LV mass and volumes.
Fig. 3 Associations of multivariable risk clusters (including information from the following risk factors: systolic and diastolic blood pressure (BP), 
waist circumference, HbA1c, and LDL-C) with CMR-traits of cardiac structure and function (N = 349). Displayed are predicted mean values for the 
CMR traits, stratified by multivariable risk cluster (representing low, medium and high cumulative risk factor exposure). The analyses were adjusted 
for age, sex, smoking status, alcohol consumption, physical activity, antihypertensive medication, lipid-lowering medication and glucose-lowering 
medication measured at Exam 3 (contemporaneous with the CMR examination). The lines connecting the dots from low to medium and high are 
for visual aid only. (***p < 0.001; **p < 0.01; *p < 0.05, reference = low-level cluster). LV = left ventricle; RV = right ventricle
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The association of systolic BP with LV mass was a 
prominent results in our analyses and agrees well with 
another study [31]. In fact, high LV mass is considered 
an integral measure of long-time exposure to high BP 
and it has previously been demonstrated in data from the 
Framingham Heart Study that systolic BP is an important 
correlate of LV mass progression over 4 years as well as 
over the adult life course [31]. However, a bit surprisingly, 
systolic BP was not significantly associated with other 
CMR traits which is in part in contrast with prior obser-
vations [9–11].
In addition, higher BMI was previously associated 
with higher LV mass and volumes not indexed by BSA 
[10] as compared to our study that demonstrated an 
inverse association of waist circumference with LV 
mass and volumes. Our results regarding the associa-
tions of BP and cholesterol levels with cardiac param-
eters are also in line with results of a CMR examination 
Table 4 Cross-sectional association of  multivariable CVD risk factor clusters from  Exam 3 (representing low, medium 
and  high exposure to  5 CVD risk factors at  this exam) with  CMR derived measures of  cardiac structure and  function 
(Model A); and  a  combined model displaying the  association of  multivariable risk factor clusters of  Exam 3 
(contemporaneous with  the  CMR) AND  of  the longitudinal (over 14-years) multivariable risk factor clusters with  MR 
derived measures of cardiac structure and function (Model B)
Data are β-coefficients (with 95% confidence interval; indicating change in outcome variable between reference cluster and risk factor cluster) from multivariable 
linear regression models adjusted for age, sex, smoking status, alcohol consumption, physical activity, antihypertensive medication, lipid-lowering medication, 
glucose-lowering medication measured in Exam 3
Ref. reference cluster
***p < 0.001; **p < 0.01; *p < 0.05
a Multivariable clusters included the risk factors systolic BP, diastolic BP, WC, HbA1c and LDL-C and were calculated by k-means clustering
b Indexed to body surface area
c Likelihood-Ratio-test for adding the longitudinal multivariable risk factor trajectory clusters to the cross-sectional multivariable risk factor clusters (Model B)
CV Risk 
factors
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LR-testa p = 0.003 p < 0.001 p = 0.068 p = 0.003 p = 0.006 p = 0.011 p < 0.001 p < 0.001
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of the RV conducted within the community-based 
MESA study [11]. In the latter study, total cholesterol 
levels were inversely associated with mass and end-
diastolic volume of the LV and RV while HDL-C was 
positively associated with end-diastolic volume in 
both ventricles. In contrast, Framingham  Heart Study 
investigators did not reveal independent associations 
between lipid concentrations and echocardiographic 
measurements of LV structure in individuals free of 
CVD [32].
While clinically overt diabetes is associated with an 
increased risk for adverse cardiac remodeling [10, 11] 
and incident heart failure [33], it is less clear, whether 
HbA1c level in a general population sample (including 
many non-diabetic individuals) confer an increased risk 
for adverse cardiac remodeling. Analyses in the like-
wise community-based SHIP study displayed a lack of 
association of HbA1c levels with LV mass index and 
fractional shortening, key ultrasonographic measures 
of cardiac structure and function, respectively [34].
Antecedent risk factor levels and CVD
Data on the association of antecedent risk factor lev-
els with clinical CVD events have been published in 
different cohort studies [35–37]. Lee and colleagues 
investigated in the Framingham Heart Study the asso-
ciations of remote (− 30 years), recent (− 20 years) and 
current (− 10  years) BP and BMI levels with incident 
heart failure and revealed that all three measurements 
of systolic BP, pulse pressure, and BMI were associ-
ated with incident heart failure independently of other 
covariates [36]. This study could not detect a significant 
impact of current, recent and remote diastolic BP on 
heart failure risk. Framingham Heart Study  investiga-
tors have also reported a positive association between 
antecedent levels of systolic BP, diastolic BP and pulse 
pressure with the 10-year risk of overall CVD events, 
including death, myocardial infarction, stroke, claudi-
cation, heart failure and others in subgroups of sex and 
age [37]. A more recent study reported that antecedent 
systolic BP was a stronger predictor of the 20-year risk 
of CVD events than current systolic BP, whereas—in 
the same sample—, antecedent hypertension was not a 
significant predictor for incident CVD [35]. A further 
study observed the relation between lipid concentra-
tions and incident heart failure over a long time period 
(mean = 26  years) and revealed a higher heart failure 
risk for higher non-HDL-C levels and a lower heart fail-
ure risk for higher HDL-C levels [38].
Risk factor trajectories and CVD
This is the first study to assess associations of repeated 
risk factor measurements and their trajectories over a 
14 year time period with CMR-based measures of cardiac 
structure and function as well as peri- and epicardial fat. 
The evidence linking risk factor trajectories to subclinical 
CVD is not yet available in contrast to the evidence for 
overt CVD.
In a community-based sample of elderly (≥ 65  years) 
individuals, BP measurements were recorded at least 4 
times over a period of 7 years. The relation of BP trajec-
tory clusters (cluster 1: increasing systolic and diastolic 
BP from low levels; cluster 2: constant systolic BP and 
decreasing diastolic BP; cluster 3: decreasing systolic 
and diastolic BP from high levels) to all-cause mortality, 
incident CVD (fatal and nonfatal cerebrovascular acci-
dents and myocardial infarctions) and incident heart 
failure resulted in cluster 3 to be exposed to highest risk 
for all three outcomes compared to cluster 1 [39]. Attard 
and colleagues reported 10 different longitudinal BMI 
trajectories from adolescence to adulthood (mean age 
17–29  years) and their association with CVD risk [40] 
over a period of 12  years. These different BMI trajecto-
ries were associated variably with higher risk of diabetes, 
hypertension and inflammation (as main risk factors for 
cardiac remodeling) [41] compared to the referent clus-
ter of constant low BMI over time in both, in women and 
men.
A further study compared metabolic and biochemical 
risk factor trajectories between a group of incident CVD 
cases and an age- and sex-matched control group over a 
time period up to 15–20 years and revealed that systolic 
BP and waist circumference trajectories were more unfa-
vorable in the CVD group compared to the control group 
[42]. However, trajectories of BMI, diastolic BP, total and 
HDL-C levels were not different between both groups 
of that latter study. This is partly in line with the results 
from our analysis, where we observed that only some 
single risk factor trajectory clusters (diastolic BP, waist 
circumference, LDL-C) were associated with selected 
cardiac parameters.
However, in our sample the multivariable clusters 
incorporating all risk factors simultaneously were signifi-
cantly associated to all cardiac outcomes except LV mass, 
which underscores the importance of taking the conjoint 
evolution of risk factors into account.
Strengths and limitations
Strengths of our study include the well-characterized 
sub-sample of the population-based KORA study, a large 
prospective cohort study with detailed and highly stand-
ardized measurements of a wide range of established 
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cardiovascular risk factors and other phenotypes. Fur-
thermore, we used advanced CMR techniques and qual-
ity assured reading procedures to characterize subclinical 
parameters of cardiac structure and function. To assess 
the associations between risk factors and CMR param-
eters we used not only risk factor measurements of the 
same examination cycle as the CMR examination (Exam 
3) but also the examination cycles 7-years and 14-years 
prior the CMR examination.
The following limitations merit consideration. We con-
ducted the CMR examination only at Exam 3. Thus, we 
were not able to investigate the associations of risk fac-
tor levels from prior exams or risk factor trajectories 
with changes in subclinical CMR parameters over time. 
However, we were able to relate longitudinal trajectories 
of multiple risk factors—in isolation and in combina-
tion—over 14 years to various CMR traits. Second, CMR 
measurements were obtained only in a subsample of the 
KORA cohort and the representativeness of this study 
sample for the initial cohort sample is limited. However, 
an analysis of cardiac parameters using statistical sam-
pling weights to attain representativeness of the CMR 
sample to the full underlying cohort revealed no major 
differences to an unweighted analysis [43]. Third, we only 
identified three clusters for each risk factor and focussed 
on the most prevalent risk factors in our study sample. 
Fourth, except for the main analyses the results were 
not adjusted for multiple comparisons, thus weak asso-
ciations remain questionable. And fifth, our sample was 
of European ancestry with unknown generalizability to 
other ethnic samples.
Perspectives
We observed strong associations between risk factors 
levels measured over a 14-years’ time horizon with sub-
clinical cardiac remodeling traits as assessed by CMR. 
These associations suggest that prevention of adverse 
cardiac remodelling should start early in life, since long 
term exposure to higher (multiple) risk factor levels 
demonstrated consistent and graded associations with 
adverse subclinical alterations of cardiac function and 
structure. Prevention strategies should include optimal 
control of modifiable risk factors, including BP, waist cir-
cumference, and LDL-C. Further studies should evaluate 
whether longitudinal risk factor information can be used 
to improve CVD risk prediction models for adverse car-
diovascular remodelling and clinically overt CVD events.
Conclusion
Long-term (14  years) exposure to elevated levels of 
to traditional CVD  risk factors—modelled individu-
ally and conjointly—were associated with adverse CMR 
traits of cardiac structure and function. Longitudinal 
multivariable trajectory clusters added significant infor-
mation to a multivariable risk profile obtained concurrent 
to the CMR examination (Table 4; Model B). Therefore, 
longitudinal multivariable trajectory clustering may allow 
better identification of individuals at high risk for cardiac 
remodelling. This premise deserves further investigation.
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